These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 35612696)
1. Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype. Ren L; Hua L; Bao Z; Deng J; Wang D; Chen J; Chen H; Juratli TA; Wakimoto H; Gong Y J Neurooncol; 2023 Jan; 161(2):193-202. PubMed ID: 35612696 [TBL] [Abstract][Full Text] [Related]
2. Skull base atypical meningioma: long term surgical outcome and prognostic factors. Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076 [TBL] [Abstract][Full Text] [Related]
3. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas. Ohba S; Kobayashi M; Horiguchi T; Onozuka S; Yoshida K; Ohira T; Kawase T J Neurosurg; 2011 May; 114(5):1278-87. PubMed ID: 21166572 [TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection. Ren L; Cheng H; Chen J; Deng J; Wang D; Xie Q; Wakimoto H; Hua L; Gong Y J Neurosurg; 2023 Jul; 139(1):49-58. PubMed ID: 36334291 [TBL] [Abstract][Full Text] [Related]
5. Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes. Ren L; Hua L; Deng J; Cheng H; Wang D; Chen J; Xie Q; Wakimoto H; Gong Y Neurosurgery; 2023 Apr; 92(4):745-755. PubMed ID: 36512828 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution. Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306 [TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas. Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972 [TBL] [Abstract][Full Text] [Related]
9. Extent of resection and survival outcomes in World Health Organization grade II meningiomas. Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354 [TBL] [Abstract][Full Text] [Related]
10. Differential Tumor Progression Patterns in Skull Base Versus Non-Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature. Savardekar AR; Patra DP; Bir S; Thakur JD; Mohammed N; Bollam P; Georgescu MM; Nanda A World Neurosurg; 2018 Apr; 112():e74-e83. PubMed ID: 29258946 [TBL] [Abstract][Full Text] [Related]
11. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas. Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940 [TBL] [Abstract][Full Text] [Related]
12. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430 [TBL] [Abstract][Full Text] [Related]
13. Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes. Khanna O; Fathi Kazerooni A; Arif S; Mahtabfar A; Momin AA; Andrews CE; Hafazalla K; Baldassari MP; Velagapudi L; Garcia JA; Sako C; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Flanders AE; Shi W; Davatzikos C Neurosurg Focus; 2023 Jun; 54(6):E17. PubMed ID: 37552657 [TBL] [Abstract][Full Text] [Related]
14. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. Palma L; Celli P; Franco C; Cervoni L; Cantore G J Neurosurg; 1997 May; 86(5):793-800. PubMed ID: 9126894 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery. Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463 [TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological predictors of outcome in malignant meningioma. Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425 [TBL] [Abstract][Full Text] [Related]
17. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma. Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312 [TBL] [Abstract][Full Text] [Related]
18. Regrowth factors of WHO grade I skull base meningiomas following incomplete resection. Park HH; Yoo J; Oh HC; Cha YJ; Kim SH; Hong CK; Lee KS J Neurosurg; 2022 Dec; 137(6):1656-1665. PubMed ID: 35453107 [TBL] [Abstract][Full Text] [Related]
19. Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients. Tao X; Wang K; Dong J; Hou Z; Wu Z; Zhang J; Liu B J Neurooncol; 2018 Feb; 136(3):515-522. PubMed ID: 29143274 [TBL] [Abstract][Full Text] [Related]
20. A comparison of clinicopathological features and surgical outcomes between pediatric skull base and non-skull base meningiomas. Li Z; Li H; Jiao Y; Ma J; Wang S; Zhao J; Cao Y Childs Nerv Syst; 2017 Apr; 33(4):595-600. PubMed ID: 27796552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]